The Current Ratio as of September 2024 (TTM) for Cadrenal Therapeutics, Inc. Common Stock (CVKD) is 3.60

According to Cadrenal Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 3.60. This represents a change of -62.46% compared to the average of 9.59 of the last 4 quarters.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Historical Current Ratio (quarterly & annually)

How has CVKD Current Ratio performed in the past?

The mean historical Current Ratio of Cadrenal Therapeutics, Inc. Common Stock over the last ten years is 5.41. The current 3.60 Current Ratio has changed 6.56% with respect to the historical average. Over the past ten years (40 quarters), CVKD's Current Ratio was at its highest in in the September 2023 quarter at 16.46. The Current Ratio was at its lowest in in the March 2022 quarter at 0.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cadrenal Therapeutics, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Average Current Ratio

How has CVKD Current Ratio performed in the past?

The current Current Ratio of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cadrenal Therapeutics, Inc. Common Stock (CVKD) Current Ratio vs. Peers

How is CVKD’s Current Ratio compared to its peers?

Cadrenal Therapeutics, Inc. Common Stock’s Current Ratio is less than Mineralys Therapeutics, Inc. (11.20), less than Structure Therapeutics Inc. (41.38), less than Centessa Pharmaceuticals plc (13.29), greater than Nuvectis Pharma, Inc. (3.17), less than Senti Biosciences, Inc. (4.89), greater than ZIVO Bioscience, Inc. (0.17), less than Foghorn Therapeutics Inc. (5.69), greater than Quoin Pharmaceuticals, Ltd. (3.35), less than Ikena Oncology, Inc. (18.22), greater than Enochian Biosciences, Inc. (0.06), less than Eliem Therapeutics, Inc. (60.41), greater than HCW Biologics Inc. (0.10), greater than Exicure, Inc. (0.61), greater than Cingulate Inc. (1.20), less than SAB Biotherapeutics, Inc. (5.24), less than Anebulo Pharmaceuticals, Inc. (5.32), less than Monopar Therapeutics Inc. (6.59), less than AN2 Therapeutics, Inc. (10.61), greater than Miromatrix Medical Inc. (3.46), greater than Inhibikase Therapeutics, Inc. (2.32), less than PMV Pharmaceuticals, Inc. (19.22),

Build a custom stock screener for Cadrenal Therapeutics, Inc. Common Stock (CVKD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cadrenal Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cadrenal Therapeutics, Inc. Common Stock (CVKD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cadrenal Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.